After finishing at $12.58 in the prior trading day, KalVista Pharmaceuticals Inc (NASDAQ: KALV) closed at $13.69, up 8.82%. In other words, the price has increased by $+1.11 from its previous closing price. On the day, 963038 shares were traded.
Ratios:
Our goal is to gain a better understanding of KALV by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.25 and its Current Ratio is at 7.25. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on June 15, 2020, initiated with a Buy rating and assigned the stock a target price of $30.
On July 29, 2019, SVB Leerink started tracking the stock assigning a Outperform rating and target price of $31.
On March 20, 2019, Needham started tracking the stock assigning a Buy rating and target price of $35.Needham initiated its Buy rating on March 20, 2019, with a $35 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 20 when Feener Edward P. sold 28,288 shares for $14.07 per share. The transaction valued at 397,929 led to the insider holds 62,157 shares of the business.
Crockett Thomas Andrew sold 24,888 shares of KALV for $351,289 on Feb 20. The CEO now owns 211,203 shares after completing the transaction at $14.11 per share. On Feb 20, another insider, Palleiko Benjamin L, who serves as the CFO, CBO of the company, sold 22,802 shares for $14.11 each. As a result, the insider received 321,846 and left with 187,315 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KALV now has a Market Capitalization of 569.16M. Its current Enterprise Value per Revenue stands at 76.33 whereas that against EBITDA is -4.06.
Stock Price History:
Over the past 52 weeks, KALV has reached a high of $16.88, while it has fallen to a 52-week low of $6.26. The 50-Day Moving Average of the stock is 13.00, while the 200-Day Moving Average is calculated to be 10.42.
Shares Statistics:
The stock has traded on average 684.39K shares per day over the past 3-months and 2.04M shares per day over the last 10 days, according to various share statistics. A total of 34.17M shares are outstanding, with a floating share count of 24.22M. Insiders hold about 41.75% of the company’s shares, while institutions hold 56.12% stake in the company. Shares short for KALV as of Jan 31, 2024 were 2.47M with a Short Ratio of 3.61, compared to 3.69M on Dec 29, 2023. Therefore, it implies a Short% of Shares Outstanding of 7.16% and a Short% of Float of 7.64%.
Earnings Estimates
Its stock is currently analyzed by 6 different market analysts. On average, analysts expect EPS of -$0.77 for the current quarter, with a high estimate of -$0.69 and a low estimate of -$0.87, while EPS last year was -$0.75. The consensus estimate for the next quarter is -$0.75, with high estimates of -$0.69 and low estimates of -$0.9.
Analysts are recommending an EPS of between -$2.84 and -$3.28 for the fiscal current year, implying an average EPS of -$3.03. EPS for the following year is -$2.63, with 5 analysts recommending between -$2.03 and -$3.13.
